Dexmedetomidine-induced decreases in accumbal dopamine in the rat are partly mediated via the locus coeruleus

Anesthesia and Analgesia

Volumn 102, Issue 2, 2006, Pages 448-455

  Whittington, Robert A ^a   Virág, László ^a  

^a Columbia University ^*  (United States)

Author keywords

[No Author keywords available]

Indexed keywords

12 ETHYLSULFONYL 5,8,8A,9,10,11,12,12A,13,13A DECAHYDRO 3 METHOXY 6H ISOQUINO[2,1 G][1,6]NAPHTHYRIDINE; ALPHA 2 ADRENERGIC RECEPTOR BLOCKING AGENT; ALPHA 2 ADRENERGIC RECEPTOR STIMULATING AGENT; DEXMEDETOMIDINE; INWARDLY RECTIFYING POTASSIUM CHANNEL;

ANIMAL EXPERIMENT; ARTICLE; CELL MEMBRANE DEPOLARIZATION; CENTRAL NERVOUS SYSTEM; CONTROLLED STUDY; DOPAMINE BRAIN LEVEL; DOPAMINE METABOLISM; DOPAMINE RELEASE; DOPAMINERGIC TRANSMISSION; DRUG ANTAGONISM; DRUG EFFECT; ELECTROCHEMICAL DETECTION; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; LOCUS CERULEUS; MALE; MICRODIALYSIS; NERVE EXCITABILITY; NONHUMAN; NORADRENERGIC SYSTEM; NUCLEUS ACCUMBENS; PRIORITY JOURNAL; RAT; SEDATION;

EID: 31444431871     PISSN: 00032999     EISSN: None     Source Type: Journal    
DOI: 10.1213/01.ane.0000195234.07413.5a     Document Type: Article

References (29)

1. Grenhoff J, Svensson TH. Clonidine modulates dopamine cell firing in rat ventral tegmental area. Eur J Pharmacol 1989;165: 11-8.
2. Grenhoff J, Nisell M, Ferre S, et al. Noradrenergic modulation of midbrain dopamine cell firing elicited by stimulation of the locus coeruleus in the rat. J Neural Transm Gen Sect 1993;93: 11-25.
3. Lategan AJ, Marien MR, Colpaert FC. Effects of locus coeruleus lesions on the release of endogenous dopamine in the rat nucleus accumbens and caudate nucleus as determined by intracerebral microdialysis. Brain Res 1990;523:134-8.
4. Gresch PJ, Sved AF, Zigmond MJ, Finlay JM. Local influence of endogenous norepinephrine on extracellular dopamine in rat medial prefrontal cortex. J Neurochem 1995;65:111-6.
5. Häidkind R, Kivastik T, Eller M, et al. Denervation of the locus coeruleus projections by treatment with the selective neurotoxin DSP-4 [N (2-chloroethyl)-N-ethyl-2-bromobenzylamine] reduces dopamine release potential in the nucleus accumbens shell in conscious rats. Neurosci Lett 2002;332:79-82.
6. Lategan AJ, Marien MR, Colpaert FC. Suppression of nigrostriatal and mesolimbic dopamine release in vivo following noradrenaline depletion by DSP-4: a microdialysis study. Life Sci 1992;50:995-9.
7. Harro J, Oreland L. Depression as a spreading adjustment disorder of monoaminergic neurons: a case for primary implication of the locus coeruleus. Brain Res Brain Res Rev 2001;38:79-128.
8. Belleville JP, Ward DS, Bloor BC, Maze M. Effects of intravenous dexmedetomidine in humans. I. Sedation, ventilation, and metabolic rate. Anesthesiology 1992;77:1125-33.
9. Scheinin H, Kallio A, Koulu M, Scheinin M. Pharmacological effects of medetomidine in humans. Acta Vet Scand Suppl 1989; 85:145-7.
10. Maier C, Steinberg GK, Sun GH, et al. Neuroprotection by the alpha 2-adrenoreceptor agonist dexmedetomidine in a focal model of cerebral ischemia. Anesthesiology 1993;79:306-12.
11. Virtanen R. Pharmacological profiles of medetomidine and its antagonist, atipamezole. Acta Vet Scand Suppl 1989;85:29-37.
12. 2-adrenoceptors: I. Receptor profile, antinociceptive and hypothermic actions in comparison with dexmedetomidine and clonidine. J Pharmacol Exp Ther 2000;295:1192-205.
13. Jorm CM, Stamford JA. Actions of the hypnotic anaesthetic, dexmedetomidine, on noradrenaline release and cell firing in rat locus coeruleus slices. Br J Anaesth 1993,71:447-9.
14. Correa-Sales C, Rabin BC, Maze M. A hypnotic response to dexmedetomidine, an alpha 2 agonist, is mediated in the locus coeruleus in rats. Anesthesiology 1992;76:948-52.
15. Chiu TH, Chen MJ, Yang YR, et al. Action of dexmedetomidine on rat locus coeruleus neurones: intracellular recording in vitro. Eur J Pharmacol 1995;285:261-8.
16. Nacif-Coelho C, Correa-Sales C, Chang LL, Maze M. Perturbation of ion channel conductance alters the hypnotic response to the alpha 2-adrenergic agonist dexmedetomidine in the locus coeruleus of the rat. Anesthesiology 1994;81:1527-34.
17. Whittington RA, Virag,L, Morishima HO, Vulliemoz Y. Dexmedetomidine decreases extracellular dopamine concentrations in the rat nucleus accumbens. Brain Res 2001;919:132-8.
18. Paxinos G, Watson C. The Rat Brain in Stereotaxic Coordinates. 3rd ed. San Diego: Academic Press, 1997:9-16, 54-60.
19. Kawahara H, Kawahara Y, Westerink BH. The noradrenaline-dopamine interaction in the rat medial prefrontal cortex studied by multi-probe microdialysis. Eur J Pharmacol 2001;418:177-86.
20. Unnerstall JR, Fernandez I, Orensanz LM. The alpha-adrenergic receptor: radiohistochemical analysis of functional characteristics and biochemical differences. Pharmacol Biochem Behav 1985;22:859-74.
21. Vulliemoz Y, Whittington RA, Virag L. The nitric oxide-cGMP system of the locus coeruleus and the hypnotic action of alpha-2 adrenergic agonists. Brain Res 1999;849:169-74.
22. Westerink BH, De Vries JB. A method to evaluate the diffusion rate of drugs from a microdialysis probe through brain tissue. J Neurosci Methods 2001;109:53-8.
23. Virag L, Whittington RA. Highly sensitive chromatographic assay for dopamine determination during in vivo cerebral microdialysis in the rat. J Chromatogr B Analyt Technol Biomed Life Sci 2002;772:267-72.
24. Ruiz-Ortega JA, Ugedo L. The stimulatory effect of clonidine on locus coeruleus neurons of rats with inactivated alpha 2-adrenoceptors: involvement of imidazoline receptors located in the nucleus paragigantocellularis. Naunyn Schmiedebergs Arch Pharmacol 1997;355:288-94.
25. King PR, Suzuki S, Louis WJ, Gundlach AL. Distribution of nonadrenergic [3H]rilmenidine binding in rat brain and kidney. Ann N Y Acad Sci 1995;763:194-207.
26. Ihalainen JA, Tanila H. In vivo regulation of dopamine and noradrenaline release by alpha2A-adrenoceptors in the mouse nucleus accumbens. J Neurochem 2004;91:49-56.
27. Pritchard TC, Hamilton RB, Norgren R. Projections of the parabrachial nucleus in the old world monkey. Exp Neurol 2000;165: 101-17.
28. Srinivasan J, Schmidt WJ. Potentiation of parkinsonian symptoms by depletion of locus coeruleus noradrenaline in 6-hydroxydopamine-induced partial degeneration of substantia nigra in rats. Eur J Neurosci 2003;17:2586-92.
29. Whittington RA, Virag L, Vulliemoz Y, et al. Dexmedetomidine increases the cocaine seizure threshold in rats. Anesthesiology 2002;97:693-700.